132 related articles for article (PubMed ID: 9160854)
1. Contribution of caudal brainstem to d-fenfluramine anorexia.
Grill HJ; Donahey JC; King L; Kaplan JM
Psychopharmacology (Berl); 1997 Apr; 130(4):375-81. PubMed ID: 9160854
[TBL] [Abstract][Full Text] [Related]
2. d-fenfluramine anorexia: dissociation of ingestion rate, meal duration, and meal size effects.
Kaplan JM; Donahey J; Baird JP; Simansky KJ; Grill HJ
Pharmacol Biochem Behav; 1997; 57(1-2):223-9. PubMed ID: 9164576
[TBL] [Abstract][Full Text] [Related]
3. Serotonin receptors in the caudal brainstem are necessary and sufficient for the anorectic effect of peripherally administered mCPP.
Kaplan JM; Song S; Grill HJ
Psychopharmacology (Berl); 1998 May; 137(1):43-9. PubMed ID: 9631955
[TBL] [Abstract][Full Text] [Related]
4. Reversal of fenfluramine and fluoxetine anorexia by 8-OH-DPAT is attenuated following raphe injection of 5,7-dihydroxytryptamine.
Currie PJ; Coscina DV; Fletcher PJ
Brain Res; 1998 Jul; 800(1):62-8. PubMed ID: 9685586
[TBL] [Abstract][Full Text] [Related]
5. The appetite suppressant d-fenfluramine reduces water intake, but not food intake, in activity-based anorexia.
Hillebrand JJ; Heinsbroek AC; Kas MJ; Adan RA
J Mol Endocrinol; 2006 Feb; 36(1):153-62. PubMed ID: 16461935
[TBL] [Abstract][Full Text] [Related]
6. Effects of systemic phenylpropanolamine and fenfluramine on serotonin activity within rat paraventricular hypothalamus.
McMahon LR; Wellman PJ
Physiol Behav; 1996 Jan; 59(1):63-9. PubMed ID: 8848492
[TBL] [Abstract][Full Text] [Related]
7. A serotonin and melanocortin circuit mediates D-fenfluramine anorexia.
Xu Y; Jones JE; Lauzon DA; Anderson JG; Balthasar N; Heisler LK; Zinn AR; Lowell BB; Elmquist JK
J Neurosci; 2010 Nov; 30(44):14630-4. PubMed ID: 21048120
[TBL] [Abstract][Full Text] [Related]
8. p-Chlorophenylalanine and fluoxetine inhibit D-fenfluramine-induced Fos expression in the paraventricular nucleus, cingulate cortex and frontal cortex but not in other forebrain and brainstem regions.
Javed A; Van De Kar LD; Gray TS
Brain Res; 1997 Nov; 774(1-2):94-105. PubMed ID: 9452197
[TBL] [Abstract][Full Text] [Related]
9. Caudal brainstem processing is sufficient for behavioral, sympathetic, and parasympathetic responses driven by peripheral and hindbrain glucagon-like-peptide-1 receptor stimulation.
Hayes MR; Skibicka KP; Grill HJ
Endocrinology; 2008 Aug; 149(8):4059-68. PubMed ID: 18420740
[TBL] [Abstract][Full Text] [Related]
10. Elevated environmental temperatures can induce hyperthermia during d-fenfluramine exposure and enhance 5-hydroxytryptamine (5-HT) depletion in the brain.
Stewart CW; Bowyer JF; Slikker W
J Pharmacol Exp Ther; 1997 Dec; 283(3):1144-50. PubMed ID: 9399987
[TBL] [Abstract][Full Text] [Related]
11. Administration of fenfluramine at different ambient temperatures produces different core temperature and 5-HT neurotoxicity profiles.
Malberg JE; Seiden LS
Brain Res; 1997 Aug; 765(1):101-7. PubMed ID: 9310399
[TBL] [Abstract][Full Text] [Related]
12. Functional consequences of central serotonin depletion produced by repeated fenfluramine administration in rats.
Baumann MH; Ayestas MA; Rothman RB
J Neurosci; 1998 Nov; 18(21):9069-77. PubMed ID: 9787010
[TBL] [Abstract][Full Text] [Related]
13. Effects of phentermine and fenfluramine on extracellular dopamine and serotonin in rat nucleus accumbens: therapeutic implications.
Baumann MH; Ayestas MA; Dersch CM; Brockington A; Rice KC; Rothman RB
Synapse; 2000 May; 36(2):102-13. PubMed ID: 10767057
[TBL] [Abstract][Full Text] [Related]
14. Hyperthermia-enhanced serotonin (5-HT) depletion resulting from D-fenfluramine (D-Fen) exposure does not evoke a glial-cell response in the central nervous system of rats.
Stewart CW; Slikker W
Brain Res; 1999 Aug; 839(2):279-82. PubMed ID: 10519050
[TBL] [Abstract][Full Text] [Related]
15. Behavioural evidence that d-fenfluramine-induced anorexia in the rat is not mediated by the 5-HT1A receptor subtype.
Vickers SP; Clifton PG; Dourish CT
Psychopharmacology (Berl); 1996 May; 125(2):168-75. PubMed ID: 8783391
[TBL] [Abstract][Full Text] [Related]
16. Synergistic interactions between fenfluramine and phentermine.
Wellman PJ; Maher TJ
Int J Obes Relat Metab Disord; 1999 Jul; 23(7):723-32. PubMed ID: 10454106
[TBL] [Abstract][Full Text] [Related]
17. Hyperthermia-enhanced serotonin (5-HT) depletion resulting from d-fenfluramine exposure is preventable.
Stewart CW; Slikker W
Life Sci; 1999; 65(15):1531-6. PubMed ID: 10574218
[TBL] [Abstract][Full Text] [Related]
18. Selective serotonin reuptake inhibitors dissociate fenfluramine's anorectic and neurotoxic effects: importance of dose, species and drug.
McCann UD; Yuan J; Hatzidimitriou G; Ricaurte GA
J Pharmacol Exp Ther; 1997 Jun; 281(3):1487-98. PubMed ID: 9190887
[TBL] [Abstract][Full Text] [Related]
19. Synergistic anorectic effect of dehydroepiandrosterone and d-Fenfluramine on the obese Zucker rat.
Gillen G; Porter JR; Svec F
Physiol Behav; 1999 Aug; 67(2):173-9. PubMed ID: 10477047
[TBL] [Abstract][Full Text] [Related]
20. Subchronic and chronic exposure to d-fenfluramine dose-dependently enhances splenic immune functions in young and old male Fischer-344 rats.
Clancy J; Lorens S
Behav Brain Res; 1996; 73(1-2):355-8. PubMed ID: 8788531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
